Trends in antimicrobial susceptibility of Gram-negative bacteria isolated from blood in Jakarta from 2002 to 2008

Journal of Infection in Developing Countries

Volumn 3, Issue 11, 2009, Pages 843-848

  Moehario, Lucky H ^a   Tjoa, Enty ^b   Kiranasari, Ariyani ^a   Ningsih, Ika ^a   Rosana, Yeva ^a   Karuniawati, Anis ^a  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b ATMA JAYA CATHOLIC UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Gram negative bacteria; Susceptibility to antibiotics

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN;

ACHROMOBACTER ANITRATUM; ACINETOBACTER; ALCALIGENES FAECALIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD FLOW; BLOOD SAMPLING; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; INDONESIA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MEDICAL INFORMATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SALMONELLA;

ACINETOBACTER CALCOACETICUS SUBSP. ANITRATUS; ALCALIGENES FAECALIS; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE SUBSP. PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI;

EID: 75749137254     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.85     Document Type: Article

References (14)

1. th edition. Ed: Etkin S, Lenker D, Mils E. Ambler, PA, Springhouse, pp. 187-188.
2. Albrecht SJ, Fishman NO, Kitchen J, Nachamkin I, Bilker WB, Hoegg C, Samel C, Barbagallo S, Arentzen J, Lautenbach E (2006) Reemergence of Gram-negative healthcare-associated bloodstream infections. Arch Intern Med 166: 1289-1294.
3. Angus DC (2000) E5 murine monoclonal antiendotoxin antibody in Gram-negative sepsis. JAMA 283: 1723-1730.
4. Seneca H and Grant JP (1976) Gram-negative sepsis and endotoxic shock. Antibiotics and Chemotherapy 21: 52-61.
5. Mehta M, Dutta P, Gupta V (2005) Antimicrobial susceptibility pattern of blood isolates from a teaching hospital in North India. J Infect Dis 58: 174-176.
6. Standard Operating Procedure for Clinical Microbiology Examination (1999) Laboratory of Microbiology of Department Microbiology, Fac. of Medicine Univ. Indonesia, Jakarta.
7. Standard Operating Procedure for Clinical Microbiology Examination (2004) Laboratory of Microbiology of Department Microbiology, Fac. of Medicine, Univ. Indonesia, Jakarta.
8. Performance Standards for Clinical Laboratory Standard Institute (CLSI), year up to date.
9. Wenzel RP, Sahm DF,Thornsberry C, Draghi DC, Jones ME, Karlowsky JA (2003) In vitro susceptibilities of Gramnegative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum Cephalosporins and comparator antimicrobials: Implications for therapy. Antimicrobial Agents and Chemotherapy 47: 3089-3098.
10. Evans M (2007) Antibiotic guidelines for the empirical treatment of sepsis in immune competent adult. Nottingham Antibiotic Guidelines Committee.
11. Leclercq R, Canton R, Giske C, Heisig P, Rossolini GM, Winstanley T (2008) Expert rules in antimicrobial susceptibility testing. European Committee on Antimicrobial Susceptibility Testing (EUCAST).
12. Stevanov C, Doikov I, Dimov R, Deenichin G, Delikostadinov G (2002) Clinical and bacteriological result from the administration of Cefepime (Maxipime) in patients with severe sepsis. Med Sci Monitoring 8: 197-102.
13. Sonck J, Laureys G and Verbeelen D. (2008) The neurotoxicity and safety of treatment with Cefepime in patients with renal failure. Nephrology Dialysis Transplantation 23: 966-970.
14. Flynn CM, Johnson DM, Jones RN (1996) In vitro efficacy of Levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains. J of Chemo 8: 411-415.